Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Biol Chem ; 283(45): 30980-9, 2008 Nov 07.
Artigo em Inglês | MEDLINE | ID: mdl-18768477

RESUMO

Calcium-dependent protein kinases (CDPKs) of Apicomplexan parasites are crucial for the survival of the parasite throughout its life cycle. CDPK1 is expressed in the asexual blood stages of the parasite, particularly late stage schizonts. We have identified two substrates of Plasmodium falciparum CDPK1: myosin A tail domain-interacting protein (MTIP) and glideosome-associated protein 45 (GAP45), both of which are components of the motor complex that generates the force required by the parasite to actively invade host cells. Indirect immunofluorescence shows that CDPK1 localizes to the periphery of P. falciparum merozoites and is therefore suitably located to act on MTIP and GAP45 at the inner membrane complex. A proportion of both GAP45 and MTIP is phosphorylated in schizonts, and we demonstrate that both proteins can be efficiently phosphorylated by CDPK1 in vitro. A primary phosphorylation of MTIP occurs at serine 47, whereas GAP45 is phosphorylated at two sites, one of which could also be detected in phosphopeptides purified from parasite lysates. Both CDPK1 activity and host cell invasion can be inhibited by the kinase inhibitor K252a, suggesting that CDPK1 is a suitable target for antimalarial drug development.


Assuntos
Proteínas do Citoesqueleto/metabolismo , Malária Falciparum/enzimologia , Proteínas de Membrana/metabolismo , Plasmodium falciparum/enzimologia , Proteínas Quinases/metabolismo , Proteínas de Protozoários/metabolismo , Animais , Antimaláricos/farmacologia , Antimaláricos/uso terapêutico , Carbazóis/farmacologia , Carbazóis/uso terapêutico , Proteínas do Citoesqueleto/genética , Inibidores Enzimáticos/farmacologia , Inibidores Enzimáticos/uso terapêutico , Alcaloides Indólicos/farmacologia , Alcaloides Indólicos/uso terapêutico , Malária Falciparum/tratamento farmacológico , Malária Falciparum/genética , Proteínas de Membrana/genética , Fosforilação/efeitos dos fármacos , Plasmodium falciparum/genética , Proteínas Quinases/genética , Proteínas de Protozoários/antagonistas & inibidores , Proteínas de Protozoários/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA